View Montra overdosage for action to be taken in the event of an overdose.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to other nitrates/nitrites. Acute circulatory failure associated w/ marked hypotension (shock & states of collapse), angle-closure glaucoma, functional or organic GI hypermotility or malabsorption syndrome; increased intracranial pressure eg, head trauma or cerebral hemorrhage; myocardial insufficiency due to obstruction eg, presence of aortic or mitral stenosis or of constrictive pericarditis. Obstructive hypertrophic cardiomyopathy, pericarditis, cardiogenic shock, postural or orthostatic hypotension, severe anemia. Concomitant use w/ PDE-5 inhibitors (eg, sildenafil, tadalafil, vardenafil).
Anginal patients w/ acute MI or CHF. Vol-depleted or hypotensive patients. Tolerance to hemodynamic & antianginal effects may develop at higher doses (>120 mg/day) &/or more frequent doses eg, bid. Avoid abrupt w/drawal. Severe cerebral arteriosclerosis; arterial hypoxia due to anemia, hypoxemia, ventilation or perfusion imbalance. May impair ability to drive or operate machinery. Pregnancy & lactation. Childn.
Sign Out
